Page 12 - Iontech News Today

Secretary for the Civil Service Ingrid Yeung says take-up rate ‘not ideal’ in light of low overall vaccination figures among city’s children aged under three years.

Introducing jobsite Door Cam security, live weather and PPE alerts for new Daily Log sections...

Shots available at Hong Kong Children’s Hospital, Gleneagles Hospital, CUHK Medical Centre and Osman Ramju Sadick Memorial Sports Centre.

Bivalent booster elicited approximately 4-fold higher neutralizing antibody titers against Omicron BA.4/BA.5 sublineages compared to the original COVID-19 vaccine in individuals older than 55 years

NEW YORK CITY (dpa-AFX) - Drug major Pfizer Inc. (PFE) and German partner BioNTech SE (BNTX) announced Friday updated data from a Phase 2/3 clinical trial for Omicron BA.4/BA.5-adapted bivalent

Pfizer and BioNTech are still conducting larger clinical trials of the updated boosters.

Germany’s chancellor has announced limited use for the BioNTech shot in mainland China for foreign residents, but he’s hopeful approval can be expanded.

When someone gets any vaccine, it can take a few weeks to build up immunity and generate its full protection.

The inoculation could simplify immunisation practices and potentially lead to better vaccine uptake for both diseases, say officials

U.S. drugmaker Pfizer Inc and its German partner BioNTech SE have started an early-stage study to evaluate a combination vaccine targeting COVID-19 and influenza, the companies said on Thursday.